While CMS has started making changes to address health equity through policy and payment models, commercial plans are waiting to see the outcomes before they follow suit, said Jayson Slotnik, partner, Health Policy Strategies, Inc.
While CMS has started making changes to address health equity through policy and payment models, commercial plans are waiting to see the outcomes before they follow suit, said Jayson Slotnik, partner, Health Policy Strategies, Inc.
Transcript
CMS is tweaking value-based payment models to address equity better. Are commercial plans already doing this or will they start following in the footsteps of CMS and begin to address equity in payment models?
So, in the last couple of years, CMS has had a significant emphasis on health equity. A significant approach introduced many policies related to trying to equitize access to health care across race, gender, age, socioeconomic status. And the ramifications of such are not really well known yet, because the policies haven't really gone into effect, number one, and certainly, we have not seen any data or results or research about health outcomes related to those efforts.
So, will commercial [plans] follow? It's hard to really say whether the commercial will follow. My guess is that they will wait and see what happens with Medicare. They will wait and see what's the outcomes of some of these innovative or different programs or investments, if you will, that CMS is making into these new policies—access, dedication to ignored areas of health care. And if they see a [return on investment] or even a better outcome that will cost them a little bit more, I want to believe that the commercial will follow.
Managed Care Cast Presents: BTK Inhibitors in Treatment-Naive Patients With CLL and MCL
December 26th 2024A trio of experts discuss the treatment of chronic lymphocytic leukemia (CLL) and mantle cell lymphoma (MCL) with Bruton tyrosine kinase (BTK) inhibitors, including cost considerations.
Listen
Disparities in Telehealth Access Undermine Adoption Among Patients With Schizophrenia
January 16th 2025The COVID-19 pandemic accelerated the widespread adoption of telemental health care, and new research indicates significant racial and ethnic disparities in access to this technology among Medicaid beneficiaries with schizophrenia.
Read More
Increased Interest in Advance Provision and Over-the-Counter Medication Abortion
January 16th 2025An increased public interest and support for medication abortion following the federal Supreme Court ruling, particularly among marginalized groups, suggests a shift towards more accessible and autonomous models of abortion care.
Read More